Treatment Decision in Oral vs Injectable Systemic Therapies in Psoriasis (Sponsored by Johnson & Johnson)
Episode Description
Joel Gelfand, MD, MSCE, FAAD interviewed by Sanna Ronkainen, MD, FAAD
This episode has been sponsored by Johnson & Johnson.
We use cookies to run this site. Analytics cookies help us understand how you use it and are off until you say yes. You can change your mind at any time from the privacy preferences icon at the bottom right.We use cookies to run this site and to understand how it's used. You can opt out at any time from the privacy preferences icon at the bottom right. Cookie policy